JNJ: Johnson & Johnson a Trusted Pharma Buy for Investors

Johnson & Johnson's broad consumer reach, product lineup and trusted name give it a keepsake status for investors. JNJ is still a buy today More 

Trade of the Day: Johnson & Johnson (JNJ)

Stock trading doesn't have to be a risky prospect, especially when using cheap options on old, familiar names like Johnson & Johnson (JNJ). More 

4 Reasons For Dividend Investors to Ignore Rising Rates

If you followed any news stories over the past year, you've been told rising rates are bad for dividend stocks. Here are 4 reason to ignore that logic. More 

TGT – Target Stock a Value in The Face of Adversity

As dividend investors, we are on the lookout for quality new candidates, and to add to our holdings of great stocks. Target is a value today, so add shares More 

5 Set-and-Forget Dividend Stocks

The best kind of dividend stocks are the kind you can set and forget because you know they'll keep paying out without crashing to the ground. More 

While The Dollar Dives, Multinational Stocks Rise

It's hard to believe, but earnings season starts in just over a week. With the dollar near a one-year low, look for these 3 multinational stocks to benefit More 

5 Pharmaceutical Stocks to Buy Now

Five pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More